FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
This piece highlights safer starter options, basic risk controls, and practical tips to protect your early crypto portfolio.
19,284 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Alphabet stands out as a durable cash engine blending a near-monopoly ad business with AI-driven cloud gains, offerin...
New data from the NAHB/Wells Fargo Cost of Housing Index shows a small improvement in affordability for 2025, driven ...
Dive into sailpoint (sail) 2027 earnings with a clear plan. We break down growth drivers, potential risks, and practi...
Occidental Petroleum shares jump as geopolitical risk and Buffett’s investment strategy collide, fueling questions ab...
The May 2026 CPI report shows inflation rose again elevated, driven by higher energy costs that squeeze household bud...
On Mar. 5, Nvidia nudges higher as investors weigh AI data-center spending and long-term earnings prospects. This sto...
A low-cost $4 treatment is gaining traction as a flesh-eating screwworm reemerges in U.S. livestock. Ranchers and vet...
A sweeping real-world study of roughly 600,000 GLP-1 users finds cravings for cigarettes, alcohol, and other addictio...
An elderly shopper nearly handed over $18,000 in cash to a scam caller. A vigilant store clerk stepped in, proving on...
An unexpected medical bill can derail finances fast. This article uses pawn stars’ corey harrison as a case study to ...
Nightrush.com announces a major editorial and platform revamp to match AI-driven personalization in iGaming, with a f...